ATLANTA, GA—An implantable coronary sinus reducer (CSR) in patients with refractory angina significantly reduces symptoms over 6 months of follow-up compared with a placebo procedure, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results